Hyperlipidemia Flashcards
lipoproteins
plasma proteins that transport cholesterol, TG, etc
hyperlipidemia
elevated lipids in blood, major of atherosclerosis
dyslipidemis
disorder of lipoprotein metabolism
LDL and VDL
promote atherosclerosis
HDL
inhibits atherosclerosis
TG
major source of fat, sever elevations–> PANCREATITIS
2CD hyperlipidemia
DM, EtOH use, hypothyroidism, hypercortisolims, acromegal, obesity, sedentary lifestyle, renal/liver, estrogens, thiazide diuretics, BB
common clinical signs? think skin
eruptive and tendinous xanthomas; xanthelasmas (xanthoma on eye)
arcus senilis?
deposition of lipid in the peripheral corneal stroma. It starts at the inferior and superior poles of the cornea and in the late stages encircles the entire circumference
lipemia retinalis
lipid depostis in retinal arteries (fundoscopy)
when do you start to screen?
if RF, immediately, if not, males at 35, females at 45
tx if high LDL and risk of CAD?
daily ASA
niacin adr?
flushing
fibric acid?
gemifibrozil, fenofibrate (Tricor)
ADR: cholelithiasis, hepatitis, myositis
ezetimibe
blocks intestinal absroption of dietary and biliary cholesterol at brush border
Framingham Heart Study
risk for MI increases by about 25% for every 5 mg/dL decrement below the median values for men and women
what drugs an decrease HDL?
BB, progesterone, anabolic steroids
what drugs and good causes high TG?
corticosteroids, estrogens, BB, retinoids; high carb diet (>60%)
metabolic syndrome criteria
3 of the following: 1) abdominal obesity Men- >40 inch women> 35 inch 2) TG >150 3)HDL M <40 W<50 4) BP >130/85 5)FBG >110
impact on vasculature- HTN
vhr: cerebral, renal
hr: carotid
DM vasculature risk
coronary
carotid, renal, peripheral
smoking
peripheral
cerebral, caroltic, coronary, renal
dyslipidemia
carotid, coronary
UPSTF screening
- Males @ increased risk for CHD screen at 20 years
- Males @ no increased risk for CHD: screen at 35 and older
- Females @ increased risk for CHD: screen at 20
- Females @ no increased risk for CHD: no recommendations for or against screening
- Peds < 20 years : insufficient evidence to recommend screening
ATP III guidelines step 1
fasting lipid panel
step 2
identify presence of CHD events or risk of CHD (PAD, AAA, CAD, DM)
step 3
Major risk factors:
smokine, HTN, Low HDL, family hx of prematrue CHD, Age (M>45, W> 55)
step 4
if 2+ risk factors, determin 10 yr risk
step 5/step 6
est. lipid goal, begin treating
* *want to lower LDL then work on TG, the HDL
tx of low HDL
first reach LDL, then intensify weight management and increase physical activity
what is the first symptom of hyperlipidemia?
none